Pretreatment Serum Levels of Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor Binding Protein-3 in Men with Advanced Non-Small Cell Lung Cancer

Background Although insulin may increase risk of some cancers, few studies have examined fasting serum insulin and lung cancer risk. Methods We examined serum insulin, glucose, and indices of insulin resistance (insulin:glucose molar ratio and homeostasis model assessment of insulin resistance [HOMA-IR]) and lung cancer risk using a case-cohort study within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Studyof Finnish men. 196 cases and 395 subcohort members were included. Insulin and glucose were measured in fasting serum collected 5–12 years pre-diagnosis. Cox proportional hazards models were utilized to estimate the relative risk of lung cancer. Results The average time between blood collection and lung cancer was 9.6 years. Fasting serum insulin levels were 8.7% higher in subcohort members than cases. After multivariable adjustment, men in the fourth quartile of insulin had a significantly higher risk of lung cancer than those in the first quartile (HR=2.10, 95%CI=1.12–3.94). A similar relationship was seen with HOMA-IR (HR=1.83, 95%CI=0.99–3.38). Risk was not strongly associated with glucose or the insulin:glucose molar ratio (Ptrend=0.55 and Ptrend=0.27, respectively). Conclusions Higher fasting serum insulin concentrations, as well as the presence of insulin resistance, appear to be associated with an elevated risk of lung cancer development. Impact Although insulin is hypothesized to increase risk of some cancers, insulin and lung cancer remains understudied. Higher insulin levels and insulin resistance were associated with increased lung cancer risk. Although smoking cessation is the best method of lung cancer prevention, other lifestyle changes that impact insulin concentrations and sensitivity may reduce lung cancer risk.

show abstract

Serum Insulin, Glucose, Indices of Insulin Resistance, and Risk of Lung Cancer

Argirion

Weinstein

Männistö

et al. 2017

Cancer Epidemiology, Biomarkers &Amp; Prevention

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Pretreatment Serum Levels of Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor Binding Protein-3 in Men with Advanced Non-Small Cell Lung Cancer

Cited by 1 publication

References 22 publications

Serum Insulin, Glucose, Indices of Insulin Resistance, and Risk of Lung Cancer

Serum Insulin, Glucose, Indices of Insulin Resistance, and Risk of Lung Cancer

Contact Info

Product

Resources

About